Paper22492479
Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG and 5 others. J Bone Miner Res, 2012. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. Papers, record 22492479. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22492479
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alendronate | Major topic |
| Bone Density | Major topic |
| Femoral Neck Fractures | Major topic |
| Femur Neck | Major topic |
| Risk Assessment | Major topic |
| Aged | |
| Aged, 80 and over | |
| Bone Density Conservation Agents | |
| Confidence Intervals | |
| Female | |
| Humans | |
| Middle Aged | |
| Placebos | |
| Spinal Fractures |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42024268 | Revised Swedish FRAX models and the establishment of age-dependent intervention thresholds. | Osteoporos Int | 2026 | https://conductscience.org/library/papers/42024268 | PubMed |
| 40134107 | 2024 Royal Australian College of General Practitioners and Healthy Bones Australia guideline for osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age. | Med J Aust | 2025 | https://conductscience.org/library/papers/40134107 | PubMed |
| 38086988 | Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study. | J Bone Miner Metab | 2024 | https://conductscience.org/library/papers/38086988 | PubMed |
| 37874461 | An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. | J Endocrinol Invest | 2024 | https://conductscience.org/library/papers/37874461 | PubMed |
| 37130601 | Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. | BMJ | 2023 | https://conductscience.org/library/papers/37130601 | PubMed |
| 36945065 | Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools. | Syst Rev | 2023 | https://conductscience.org/library/papers/36945065 | PubMed |
| 34130365 | Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial. | J Bone Metab | 2021 | https://conductscience.org/library/papers/34130365 | PubMed |
| 33537844 | Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study. | Osteoporos Int | 2021 | https://conductscience.org/library/papers/33537844 | PubMed |
| 33082721 | The Effect of Type of Femoral Component Fixation on Mortality and Morbidity after Hip Hemiarthroplasty: A Systematic Review and Meta-Analysis. | HSS J | 2020 | https://conductscience.org/library/papers/33082721 | PubMed |
| 31009947 | Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review. | Ann Intern Med | 2019 | https://conductscience.org/library/papers/31009947 | PubMed |
| 30382424 | A brief history of FRAX. | Arch Osteoporos | 2018 | https://conductscience.org/library/papers/30382424 | PubMed |
| 30324412 | European guidance for the diagnosis and management of osteoporosis in postmenopausal women. | Osteoporos Int | 2019 | https://conductscience.org/library/papers/30324412 | PubMed |
| 29869039 | Review of the guideline of the American College of Physicians on the treatment of osteoporosis. | Osteoporos Int | 2018 | https://conductscience.org/library/papers/29869039 | PubMed |
| 28474780 | The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study. | J Bone Miner Res | 2017 | https://conductscience.org/library/papers/28474780 | PubMed |
| 26768394 | Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative. | Gerontologist | 2016 | https://conductscience.org/library/papers/26768394 | PubMed |
| 26593163 | Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate. | Saudi Med J | 2015 | https://conductscience.org/library/papers/26593163 | PubMed |
| 26564226 | The real enemy is fragility fracture, not osteoporosis. | Osteoporos Int | 2016 | https://conductscience.org/library/papers/26564226 | PubMed |
| 25199574 | Goal-directed treatment of osteoporosis in Europe. | Osteoporos Int | 2014 | https://conductscience.org/library/papers/25199574 | PubMed |
| 24994809 | Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study. | BMJ | 2014 | https://conductscience.org/library/papers/24994809 | PubMed |
| 24577348 | The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. | Osteoporos Int | 2014 | https://conductscience.org/library/papers/24577348 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22492479
GET https://conductscience.org/api/papers/v1/22492479/cited_by?page=2